| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, ISO 9001, USP, BP |
| Suitable for: | Adult |
| State: | Solid |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Pharmaceutical Intermediate Smart Drugs CAS 102767-28-2 Etiracetam Powder
| Product name:Etiracetam Powder |
| Other Name: 2-(2-oxopyrrolidin-1-yl)butanamide |
| Appearance:White Powder |
| CAS:33996-58-6 |
| M.F.:C8H14N2O2 |
| M.W.:170.21 |
| Specification:99% |
Etiracetam is the racemate of Levetiracetam, and it is also an impurity in the synthesis of Levetiracetam. Levetiracetam, the chemical name is (S)-α-ethyl-2-oxo-1-pyrrolidine acetamide. It is a second-generation acetylcholine agonist developed by the Belgian UCB company for the treatment of localized and secondary generalized epilepsy.
Related Product
|
Product's Name
|
CAS
|
Purity
|
|
Nooglutyl
|
112193-35-8
|
99%
|
|
Noopept
|
157115-85-0
|
99%
|
|
Compound 7P
|
1890208-58-8
|
99%
|
|
Piracetam
|
7491-74-9
|
99%
|
|
Aniracetam
|
72432-10-1
|
99%
|
|
Nefiracetam
|
77191-36-7
|
99%
|
|
Pramiracetam
|
68497-62-1
|
99%
|
|
Oxiracetam
|
62613-82-5
|
99%
|
|
Fasoracetam
|
110958-19-5
|
99%
|
|
Sunifiram
|
314728-85-3
|
99%
|
|
Coluracetam
|
135463-81-9
|
99%
|
|
N-Methyl-D-aspartic acid(NMDA)
|
6384-92-5
|
99%
|
|
Alpha GPC(Choline Alfoscerate)
|
28319-77-9
|
99%
|
|
Alpha GPC(Choline Alfoscerate)
|
28319-77-9
|
50%
|
|
Citicoline
|
987-78-0
|
99%
|
|
Galantamine Hydrobromide
|
69353-21-5
|
99%
|
|
PRL-8-53
|
51352-87-5
|
99%
|
|
NSI-189 Phosphate
|
1270138-41-4
|
99%
|
|
NSI-189
|
1270138-40-3
|
99%
|
|
Tianeptine
|
66981-73-5
|
99%
|
|
Tianeptine sodium
|
30123-17-2
|
99%
|
|
Tianeptine hemisulfate monohydrate (THM)
|
1224690-84-9
|
99%
|
|
J-147
|
1146963-51-0
|
99%
|
| ITEM | SPECIFICATION | RESULT | METHOD |
| Appearance | White powder, neutral odor, highly hygroscopic | Conforms | Visual |
| Identification | Standard solution and test solution same spot,RF | Conforms | TLC |
| Specific Optical | -2.4°~ -2.8° | -2.72° | |
| Heavy metals (as PB) | ≤10ppm | Conforms | AAS |
| Sulfate (SO4) | ≤0.02% | Conforms | Colorimetry |
| Chloride (Cl) | ≤0.02% | Conforms | Colorimetry |
| Phosphate Ion (P) | ≤5ppm | Conforms | Colorimetry |
| Residual solvent(ethanol) | ≤1.0% | Conforms | HS-GC |
| pH | 4.5~7.0 | 5.10 | |
| Related substance | Spot not bigger than standard solution spot | No spot | TLC |
| Water Content | ≤2% | 0.26% | KF |
| Assay (dried basis) | 98.0%--102.0% | 99.48% | Potentiometric titration |
| Assay (dried basis) | 98.5%--100% | 99.2% | HPLC |
Function:
Etiracetam is a chiral compound, and its dextrorotatory body [( R)-2-(2-oxo-1-pyrrolidine)butanamide has only a slight or insignificant pharmacological effect on the suppression of epileptic seizures. The quality of the raw materials used in synthetic drugs often directly affects the quality of the products. In order to ensure the safety, stability and effectiveness of the product Etiracetam, it is extremely necessary to conduct quality assessment of the pharmacological and chemical properties of the raw materials.
Application:
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}